• 1. Electrochemical characterization of hydroquinone derivatives with different substituents in acetonitrile
  Ricardo Salazar,Jorge Vidal,Maximiliano Martínez-Cifuentes,Ramiro Araya-Maturana,Oney Ramírez-Rodríguez New J. Chem. 2015 39 1237

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 2,5-Dihydroxyphenacyl Bromide (CAS No. 25015-91-2)

2,5-Dihydroxyphenacyl Bromide, identified by the Chemical Abstracts Service Number (CAS No.) 25015-91-2, is a significant compound in the realm of organic chemistry and pharmaceutical research. This compound has garnered attention due to its unique structural properties and potential applications in medicinal chemistry. The presence of both hydroxyl and bromine substituents on a phenacyl core makes it a versatile intermediate for synthesizing more complex molecules, particularly in the development of bioactive agents.

The structure of 2,5-Dihydroxyphenacyl Bromide features a phenacyl group (C?H?C(O)NH) with hydroxyl groups at the 2- and 5-positions, further functionalized with a bromine atom at the 4-position. This arrangement imparts distinct reactivity patterns, making it a valuable building block for further chemical modifications. The compound’s solubility characteristics and stability under various conditions have been thoroughly investigated, providing insights into its handling and application in synthetic protocols.

In recent years, there has been growing interest in 2,5-Dihydroxyphenacyl Bromide due to its role as a precursor in the synthesis of pharmacologically active compounds. Research has demonstrated its utility in constructing heterocyclic scaffolds, which are prevalent in many drugs targeting neurological disorders, infectious diseases, and cancer. The bromine substituent, in particular, offers a handle for palladium-catalyzed cross-coupling reactions, enabling the introduction of diverse functional groups with high precision.

One of the most compelling aspects of 2,5-Dihydroxyphenacyl Bromide is its application in the development of antimicrobial agents. Studies have shown that derivatives of this compound exhibit promising activity against Gram-positive bacteria and fungi. The hydroxyl groups contribute to hydrogen bonding interactions with biological targets, while the phenacyl core enhances lipophilicity, improving membrane permeability. This dual functionality makes it an attractive candidate for further optimization.

Furthermore, 2,5-Dihydroxyphenacyl Bromide has been explored as an intermediate in the synthesis of anticancer drugs. Researchers have leveraged its reactivity to introduce alkylating groups or other bioisosteric moieties that disrupt DNA replication or induce apoptosis in tumor cells. Preliminary studies indicate that certain derivatives show significant cytotoxicity against multiple cancer cell lines without notable toxicity to healthy cells. This balance is crucial for developing effective chemotherapeutic agents.

The pharmacokinetic properties of 2,5-Dihydroxyphenacyl Bromide and its derivatives have also been scrutinized. Metabolic stability studies suggest that the compound undergoes predictable biotransformation pathways, allowing for rational drug design. Additionally, computational modeling has been employed to predict binding affinities and optimize lead structures based on this scaffold. These advancements underscore the compound’s importance as a pharmacophore in modern drug discovery.

In conclusion, 2,5-Dihydroxyphenacyl Bromide (CAS No. 25015-91-2) represents a compelling tool for synthetic chemists and medicinal chemists alike. Its unique structural features and reactivity profile enable the construction of novel bioactive molecules with potential therapeutic applications across multiple disease areas. As research continues to uncover new synthetic methodologies and biological activities associated with this compound, its significance is expected to grow further.

• 2491-37-4(2-Bromo-3'-hydroxyacetophenone)
• 67029-82-7(2-Bromo-1-(1-hydroxynaphthalen-2-yl)ethanone)
• 1204-21-3(2-bromo-1-(2,5-dimethoxyphenyl)ethan-1-one)
• 2491-39-6(2-Bromo-1-(2,4-dihydroxyphenyl)ethanone)
• 14386-64-2(2-Bromo-1-3,5-di(tert-butyl)-4-hydroxyphenylethan-1-one)
• 2491-36-3(2-Bromo-2’-hydroxyacetophenone)
• 115787-50-3(5-(Bromoacetyl)salicylaldehyde)
• 203524-87-2(Ethanone,2-bromo-1-(2-hydroxy-5-methoxyphenyl)-)
• 145964-98-3(2-bromo-1-(2-methoxy-4-methylphenyl)ethan-1-one)
• 101386-50-9(2-bromo-1-[4-hydroxy-3-(2-hydroxyethyl)phenyl]ethanone)